A pilot study from WuXi Biologics suggests existing fed-batch facilities could achieve an eightfold improvement in downstream ...

Minimum Sample Size To Lock Control Limits? A Capability- and Risk-Based Approach Using PpK and Chi-Square Uncertainty When deployed correctly, statistical process control (SPC) reduces deviation ...

Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.

BioProcess International reviews key biotech trends from the first half of 2026, including US onshoring, China's biologics ...

Fill and finish is critical to product integrity, but evolving EU GMP Annex 1, PUPSIT, single-use systems, and more demand ...

New York invests $65M in biotech with new clinical trial consortium and Biogenesis Park to compete with Boston, San Francisco ...

Learn about emerging standards for biologics that support efficient development and regulatory review, regulatory convergence ...

Allogeneic therapies based on healthy-donor material should help to create scalable processes for “off-the-shelf” drugs, potentially reducing production costs and increasing accessibility, however, ...

Earlier this month, data analytics and consulting firm GlobalData released a report citing an increasingly widening ...

Continuous Bioprocessing Yields Major Gains in Biopharmaceutical Manufacturing For many biopharmaceutical organizations, the question is no longer whether to use continuous bioprocessing at all, but ...

Explore the latest news and expert commentary on Single Use, brought to you by the editors of BioProcess International ...

If you have an account with us, sign in to persist your opt-out. If you do not have an account, you may opt-out of the ...